News and Alerts
This page is your source for pharmacy-related safety alerts, drug recalls, announcements of generic drug releases and other medication-related information.
Effective July 1, 2015, Humana will remove two drugs used to treat hepatitis C, Olysio and Victrelis, from its Medicare formularies. Two other drugs used to treat hepatitis C, Sovaldi and Harvoni, will remain on the formularies.
Patients taking Olysio and Victrelis as of June 30, 2015, will not be impacted by this change. These patients will have the same coverage for these medications until the end of the plan year.
Prescribers with questions regarding this change may call 1-800-555-CLIN (1-800-555-2546). Assistance is available Monday through Friday, 8 a.m. to 8 p.m. Eastern time. Please fax formulary exception requests to 1-877-486-2621 or mail them to: Humana Clinical Pharmacy Review, Attn: Medicare Part D coverage Determination, P.O. Box 33008, Louisville, KY 40128.
Effective Feb. 20, 2015, generic Nexium (esomeprazole) is not covered under any Humana Medicare Part D plan. Brand-name Nexium will continue to be covered on the preferred tier for all Humana Medicare Part D plans. Humana also will continue to cover generic Nexium on all commercial plans.
Prescribers with questions regarding this change may call 1-800-555-CLIN (1-800-555-2546) Monday through Friday, 8 a.m. to 8 p.m. Eastern time for more information.